- Ongoing, recruitingTherapeutic exploratory (Phase II)
Adjuvant dendritic cell immunotherapy complementing conventional therapy for pediatric patients with high-grade glioma and diffuse intrinsic pontine glioma
This study is looking at a new type of treatment called a 'dendritic cell vaccine' for children with certain types of brain tumours (high-grade glioma and DIPG). It aims to see if the vaccine is safe and practical to use alongside their usual treatments.
For: High-grade glioma (HGG) · Diffuse intrinsic pontine glioma (DIPG)Belgium - Ongoing, recruitingTherapeutic exploratory (Phase II)
First-line immunotherapy using Wilms’ tumor protein 1 (WT1)-targeted dendritic cell vaccinations for malignant pleural mesothelioma
This study is testing a new vaccine for a type of lung cancer called malignant pleural mesothelioma. Researchers want to see if this vaccine, given with chemotherapy, is safe and helps patients live longer or keeps their cancer from growing.
For: Malignant Pleural MesotheliomaBelgium